SCHEMBL731628

SCHEMBL731628

COC(OC)[SiH2]CC(C)CCl

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555576 0.78 ALDH1A1 (0.30)
SCHEMBL734469 0.77 LMNA (0.35)
SCHEMBL375876 0.76
SCHEMBL23521422 0.74
SCHEMBL1702223 0.73
SCHEMBL8464619 0.72
SCHEMBL5418098 0.71
SCHEMBL55703 0.71
SCHEMBL612550 0.70
SCHEMBL29923856 0.70 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138365-B2 Method for producing organosilanes EVONIK DEGUSSA GMBH (DE) 2012-03-20 US claimed
US-20100217026-A1 Method for producing organosilanes EVONIK OPERATIONS GMBH (DE) 2010-08-26 US claimed
EP-2057172-B1 METHOD FOR PRODUCING ORGANOSILANES EVONIK DEGUSSA GMBH (DE) 2013-09-11 EP disclosed
CN-101511848-B Method for producing organosilanes EVONIK DEGUSSA GMBH 2012-08-29 CN disclosed
US-8138365-B2 Method for producing organosilanes EVONIK DEGUSSA GMBH (DE) 2012-03-20 US disclosed
US-20100217026-A1 Method for producing organosilanes EVONIK OPERATIONS GMBH (DE) 2010-08-26 US disclosed
CN-101511848-A Method for producing organosilanes EVONIK DEGUSSA GMBH (DE) 2009-08-19 CN disclosed
EP-0676403-B1 Arylaminosilane end-capped urethane sealants WITCO CORP (US) 1999-09-15 EP disclosed
EP-0586241-B1 Azasilacycloalkyl functional alkoxysilanes and azasilacycloalkyl functional tetramethyldisiloxanes DOW CORNING (US) 1997-04-09 EP disclosed
EP-0586240-B1 Alkoxy endblocked polydiorganosiloxane and room temperature vulcanizable silicone elastomers made therefrom DOW CORNING (US) 1996-12-18 EP disclosed
EP-0499407-B1 Crosslinkers and chain extenders for room temperature vulcanization or crosslinking of polymers DOW CORNING (US) 1996-10-02 EP disclosed
EP-0586240-A2 Alkoxy endblocked polydiorganosiloxane and room temperature vulcanizable silicone elastomers made therefrom DOW CORNING CORPORATION (US) 1994-03-09 EP disclosed
US-5276123-A Endblocking polysiloxanes DOW CORNING CORPORATION (US) 1994-01-04 US disclosed
US-5239099-A Room temperature vulcanization; noncorrosive byproducts DOW CORNING CORPORATION (US) 1993-08-24 US disclosed
US-5238988-A Rapid cure room temperature vulcanizable organosiloxane compositions DOW CORNING CORPORATION (US) 1993-08-24 US disclosed
US-5162560-A Chemical intermediates DOW CORNING CORPORATION (US) 1992-11-10 US disclosed
EP-0499409-A1 Olefinic and acetylenic azasilacyclopentanes DOW CORNING CORPORATION (US) 1992-08-19 EP disclosed
EP-0499407-A1 Crosslinkers and chain extenders for room temperature vulcanization or crosslinking of polymers DOW CORNING CORPORATION (US) 1992-08-19 EP disclosed
US-5136064-A Reacting organosilicon compound with grignard reagent in presence of ether, then acetyl chloride and lewis acid and amine DOW CORNING CORPORATION (US) 1992-08-04 US disclosed
US-5110967-A No evolution of volatile by-products; sealants DOW CORNING CORPORATION (US) 1992-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100217026-A1 Method for producing organosilanes TST, STS, HAO2 MAPK1 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.